Inventor · disambiguated record
Thierry Levade
Also filed as: LEVADE THIERRY
5 granted patents·5 pending applications·7 citations·filing 2015–2025
68Inventor score
Top patents by PatentIndex Score
10 records- 0186US10822415B2Methods for enhancing the potency of the immune checkpoint inhibitorsINST NAT SANTE RECH MED·Filed 2017·Granted Nov 3, 2020·5 cites·7 claims
- 0281US10918737B2Methods and pharmaceutical composition for the treatment of cancerINST NAT SANTE RECH MED·Filed 2017·Granted Feb 16, 2021·2 cites·8 claims
- 0367US2025262318A1Methods and pharmaceutical composition for the treatment of cancerINST NAT SANTE RECH MED·Filed 2025·Application pending·0 cites
- 0461US2021145977A1Methods and pharmaceutical composition for the treatment of cancerINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 0560US2021040215A1Methods for enhancing the potency of the immune checkpoint inhibitorsINST NAT SANTE RECH MED·Filed 2020·Application pending·0 cites
- 0645US2022160692A1Use of sk2 inhibitors in combination with immune checkpoint blockade therapy for the treatment of cancerINST NAT SANTE RECH MED·Filed 2020·Application pending·0 cites
- 0742US11078277B2Methods and pharmaceutical compositions for enhancing CD8+ T cell-dependent immune responses in subjects suffering from cancerINST NAT SANTE RECH MED·Filed 2017·Granted Aug 3, 2021·0 cites·8 claims
- 0841US2021080467A1Use of sk1 as biomarker for predicting response to immunecheckpoint inhibitorsINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 0926US10144772B2Method for treating melanomaINST NAT SANTE RECH MED·Filed 2015·Granted Dec 4, 2018·0 cites·12 claims
- 1025US9851358B2Methods and pharmaceutical compositions for preventing or reducing metastatic disseminationINSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICALE·Filed 2015·Granted Dec 26, 2017·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Thierry Levade files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →